Global spatial dynamics and vaccine-induced fitness changes of Bordetella pertussis

As with other pathogens, competitive interactions between Bordetella pertussis strains drive infection risk. Vaccines are thought to perturb strain diversity through shifts in immune pressures; however, this has rarely been measured because of inadequate data and analytical tools. We used 3344 sequences from 23 countries to show that, on average, there are 28.1 transmission chains circulating within a subnational region, with the number of chains strongly associated with host population size. It took 5 to 10 years for B. pertussis to be homogeneously distributed throughout Europe, with the same time frame required for the United States. Increased fitness of pertactin-deficient strains after implementation of acellular vaccines, but reduced fitness otherwise, can explain long-term genotype dynamics. These findings highlight the role of vaccine policy in shifting local diversity of a pathogen that is responsible for 160,000 deaths annually. Description Genomic analyses of Bordetella pertussis reveal spatial structure, rate of geographic spread, and fitness shifts in response to vaccine changes. Immunity-induced pathogen evolution Population immunity is thought to drive pathogen evolutionary dynamics, but this can be hard to measure. Considering the switch from whole-cell vaccines to acellular vaccines (ACVs) as a natural experiment, Lefrancq et al. analyzed the diversity of B. pertussis genome isolates from five continents to infer local changes in strain fitness after ACV introduction. Their analysis provides evidence that ACVs have led to the increased fitness of strains lacking the virulence factor pertactin and may have implications for understanding asymptomatic B. pertussis infection.

[1]  P. Rohani,et al.  Asymptomatic Bordetella pertussis infections in a longitudinal cohort of young African infants and their mothers , 2021, eLife.

[2]  J. Sane,et al.  Widespread circulation of pertussis in Finland during 1968-1972 when the whole cell vaccine was in use. , 2021, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[3]  E. Harvill,et al.  Pertactin-Deficient Bordetella pertussis, Vaccine-Driven Evolution, and Reemergence of Pertussis , 2021, Emerging infectious diseases.

[4]  S. Cauchemez,et al.  Impact of Vaccine Schedule Change on Pertussis Epidemiology in France: A Modelling and Serological Study , 2021 .

[5]  C. Chiu,et al.  Emerging macrolide resistance in Bordetella pertussis in mainland China: Findings and warning from the global pertussis initiative , 2021, The Lancet regional health. Western Pacific.

[6]  Carl A. B. Pearson,et al.  Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England , 2021, Science.

[7]  J. Corander,et al.  Frequency-dependent selection can forecast evolution in Streptococcus pneumoniae , 2020, PLoS biology.

[8]  S. Brisse,et al.  Determining Factors for Pertussis Vaccination Policy: A Study in Five EU Countries , 2019, Vaccines.

[9]  S. Brisse,et al.  Genome characteristics of Bordetella pertussis isolates from Tunisia. , 2019, Journal of medical microbiology.

[10]  Andries J. van Tonder,et al.  Pneumococcal lineages associated with serotype replacement and antibiotic resistance in childhood invasive pneumococcal disease in the post-PCV13 era: an international whole-genome sequencing study , 2019, The Lancet. Infectious diseases.

[11]  Daniel L. Ayres,et al.  BEAGLE 3: Improved Performance, Scaling, and Usability for a High-Performance Computing Library for Statistical Phylogenetics , 2019, Systematic biology.

[12]  J. Mertsola,et al.  Pertactin-deficient Bordetella pertussis isolates: evidence of increased circulation in Europe, 1998 to 2015 , 2019, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[13]  C. Tay,et al.  Genomic epidemiology of Iranian Bordetella pertussis: 50 years after the implementation of whole cell vaccine , 2019, Emerging microbes & infections.

[14]  S. Octavia,et al.  Genomic epidemiology of erythromycin-resistant Bordetella pertussis in China , 2019, Emerging microbes & infections.

[15]  M. Tondella,et al.  Genomic Survey of Bordetella pertussis Diversity, United States, 2000–2013 , 2018, Emerging infectious diseases.

[16]  S. Brisse,et al.  Genomic Sequencing of Bordetella pertussis for Epidemiology and Global Surveillance of Whooping Cough , 2018, Emerging infectious diseases.

[17]  Aldert L. Zomer,et al.  Bordetella pertussis population dynamics and phylogeny in Japan after adoption of acellular pertussis vaccines , 2018, Microbial genomics.

[18]  M. Suchard,et al.  Posterior summarisation in Bayesian phylogenetics using Tracer , 2022 .

[19]  Lori Rowe,et al.  Screening and Genomic Characterization of Filamentous Hemagglutinin-Deficient Bordetella pertussis , 2018, Infection and Immunity.

[20]  Daniel L. Ayres,et al.  Bayesian phylogenetic and phylodynamic data integration using BEAST 1.10 , 2018, Virus evolution.

[21]  Hao Li,et al.  Pertussis Outbreak in a Primary School in China: Infection and Transmission of the Macrolide-resistant Bordetella pertussis , 2017, The Pediatric infectious disease journal.

[22]  M. Gutmann,et al.  Frequency-dependent selection in vaccine-associated pneumococcal population dynamics , 2017, Nature Ecology & Evolution.

[23]  P. Dítě,et al.  Seroepidemiology of whooping cough in the Czech Republic: estimates of incidence of infection in adults. , 2017, Public health.

[24]  E. Nelson,et al.  An update of the global burden of pertussis in children younger than 5 years: a modelling study. , 2017, The Lancet. Infectious diseases.

[25]  Y. Arakawa,et al.  Significant Decrease in Pertactin-Deficient Bordetella pertussis Isolates, Japan , 2017, Emerging infectious diseases.

[26]  Chonticha Klungthong,et al.  Dengue diversity across spatial and temporal scales: Local structure and the effect of host population size , 2017, Science.

[27]  Lori Rowe,et al.  The History of Bordetella pertussis Genome Evolution Includes Structural Rearrangement , 2017, Journal of bacteriology.

[28]  L. Valinsky,et al.  Whole-genome sequencing and comparative genomic analysis of Bordetella pertussis isolates from the 2007-2008 epidemic in Israel. , 2017, The Journal of infection.

[29]  Aki Vehtari,et al.  Practical Bayesian model evaluation using leave-one-out cross-validation and WAIC , 2015, Statistics and Computing.

[30]  V. Sintchenko,et al.  Better colonisation of newly emerged Bordetella pertussis in the co-infection mouse model study. , 2016, Vaccine.

[31]  H. Aloulou,et al.  The Re-Emergence of Whooping Cough in Sfax (Southern Tunisia) , 2016 .

[32]  Lori Rowe,et al.  Genome Structural Diversity among 31 Bordetella pertussis Isolates from Two Recent U.S. Whooping Cough Statewide Epidemics , 2016, mSphere.

[33]  David S. Wishart,et al.  PHASTER: a better, faster version of the PHAST phage search tool , 2016, Nucleic Acids Res..

[34]  V. Sintchenko,et al.  Genomic dissection of Australian Bordetella pertussis isolates from the 2008-2012 epidemic. , 2016, The Journal of infection.

[35]  A. van Belkum Hidden Staphylococcus aureus Carriage: Overrated or Underappreciated? , 2016, mBio.

[36]  Tanya A Halse,et al.  Bordetella pertussis Strain Lacking Pertactin and Pertussis Toxin , 2016, Emerging infectious diseases.

[37]  Andrew Rambaut,et al.  Exploring the temporal structure of heterochronous sequences using TempEst (formerly Path-O-Gen) , 2016, Virus evolution.

[38]  V. Sintchenko,et al.  Pertactin negative Bordetella pertussis demonstrates higher fitness under vaccine selection pressure in a mixed infection model. , 2015, Vaccine.

[39]  A. Marchand-Austin Bordetella pertussis: Whole Genome Sequence Analysis and its Application to Public Health Laboratory Surveillance , 2015 .

[40]  N. Carbonetti Contribution of pertussis toxin to the pathogenesis of pertussis disease. , 2015, Pathogens and disease.

[41]  S. Godreuil,et al.  Mycobacterium tuberculosis: ecology and evolution of a human bacterium. , 2015, Journal of medical microbiology.

[42]  Daniel Standage,et al.  The khmer software package: enabling efficient nucleotide sequence analysis , 2015, F1000Research.

[43]  L. Hurst,et al.  Genomic analysis of isolates from the United Kingdom 2012 pertussis outbreak reveals that vaccine antigen genes are unusually fast evolving. , 2015, The Journal of infectious diseases.

[44]  Jacqueline A. Keane,et al.  Rapid phylogenetic analysis of large samples of recombinant bacterial whole genome sequences using Gubbins , 2014, Nucleic acids research.

[45]  A. von Haeseler,et al.  IQ-TREE: A Fast and Effective Stochastic Algorithm for Estimating Maximum-Likelihood Phylogenies , 2014, Molecular biology and evolution.

[46]  E. Wald,et al.  The Group A Streptococcal Carrier State Reviewed: Still an Enigma. , 2014, Journal of the Pediatric Infectious Diseases Society.

[47]  G. Dore,et al.  Pertactin deficient Bordetella pertussis present a better fitness in mice immunized with an acellular pertussis vaccine. , 2014, Vaccine.

[48]  Q. He,et al.  High prevalence of erythromycin-resistant Bordetella pertussis in Xi'an, China. , 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[49]  J. Wallinga,et al.  Serial intervals of respiratory infectious diseases: a systematic review and analysis. , 2014, American journal of epidemiology.

[50]  A. Gorringe,et al.  Bordetella pertussis fimbriae (Fim): relevance for vaccines , 2014, Expert review of vaccines.

[51]  N. Klein Licensed pertussis vaccines in the United States , 2014, Human vaccines & immunotherapeutics.

[52]  F. Mooi,et al.  Investigations into the emergence of pertactin-deficient Bordetella pertussis isolates in six European countries, 1996 to 2012. , 2014, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[53]  M. Quail,et al.  Global Population Structure and Evolution of Bordetella pertussis and Their Relationship with Vaccination , 2014, mBio.

[54]  V. Sintchenko,et al.  Rapid Increase in Pertactin-deficient Bordetella pertussis Isolates, Australia , 2014, Emerging infectious diseases.

[55]  H. de Lencastre,et al.  Low Prevalence of Pneumococcal Carriage and High Serotype and Genotype Diversity among Adults over 60 Years of Age Living in Portugal , 2014, PloS one.

[56]  Junzhi Wang,et al.  Seroprevalence of pertussis in China , 2014, Human vaccines & immunotherapeutics.

[57]  H. Hallander,et al.  Antibody Responses to Bordetella pertussis Fim2 or Fim3 following Immunization with a Whole-Cell, Two-Component, or Five-Component Acellular Pertussis Vaccine and following Pertussis Disease in Children in Sweden in 1997 and 2007 , 2013, Clinical and Vaccine Immunology.

[58]  S. Brisse,et al.  AlienTrimmer: a tool to quickly and accurately trim off multiple short contaminant sequences from high-throughput sequencing reads. , 2013, Genomics.

[59]  A. V. D. van der Ark,et al.  Genome-Wide Gene Expression Analysis of Bordetella pertussis Isolates Associated with a Resurgence in Pertussis: Elucidation of Factors Involved in the Increased Fitness of Epidemic Strains , 2013, PloS one.

[60]  Heng Li Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM , 2013, 1303.3997.

[61]  F. Mooi,et al.  Pertussis resurgence: waning immunity and pathogen adaptation – two sides of the same coin , 2013, Epidemiology and Infection.

[62]  Yongchao Liu,et al.  Musket: a multistage k-mer spectrum-based error corrector for Illumina sequence data , 2013, Bioinform..

[63]  P. Rohani,et al.  Perplexities of pertussis: recent global epidemiological trends and their potential causes , 2013, Epidemiology and Infection.

[64]  F. Mooi,et al.  Small Mutations in Bordetella pertussis Are Associated with Selective Sweeps , 2012, PloS one.

[65]  G. Dore,et al.  Evolution of French Bordetella pertussis and Bordetella parapertussis isolates: increase of Bordetellae not expressing pertactin. , 2012, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[66]  T. Skoff,et al.  Population Diversity among Bordetella pertussis Isolates, United States, 1935–2009 , 2012, Emerging infectious diseases.

[67]  Sergey I. Nikolenko,et al.  SPAdes: A New Genome Assembly Algorithm and Its Applications to Single-Cell Sequencing , 2012, J. Comput. Biol..

[68]  T. Clark,et al.  Pertussis control: time for something new? , 2012, Trends in microbiology.

[69]  Y. Arakawa,et al.  Prevalence and Genetic Characterization of Pertactin-Deficient Bordetella pertussis in Japan , 2012, PloS one.

[70]  Steven Salzberg,et al.  BIOINFORMATICS ORIGINAL PAPER , 2004 .

[71]  Marcel Martin Cutadapt removes adapter sequences from high-throughput sequencing reads , 2011 .

[72]  Luis-Miguel Chevin,et al.  On measuring selection in experimental evolution , 2010, Biology Letters.

[73]  M. DePristo,et al.  The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. , 2010, Genome research.

[74]  Sumio Watanabe,et al.  Asymptotic Equivalence of Bayes Cross Validation and Widely Applicable Information Criterion in Singular Learning Theory , 2010, J. Mach. Learn. Res..

[75]  G. Dore,et al.  First report and detailed characterization of B. pertussis isolates not expressing Pertussis Toxin or Pertactin. , 2009, Vaccine.

[76]  Alexei J. Drummond,et al.  Bayesian Phylogeography Finds Its Roots , 2009, PLoS Comput. Biol..

[77]  F. Mooi,et al.  Bordetella pertussis Strains with Increased Toxin Production Associated with Pertussis Resurgence , 2009, Emerging infectious diseases.

[78]  F. Mooi,et al.  Improving pertussis vaccination , 2009, Human vaccines.

[79]  M. Maiden,et al.  Meningococcal carriage and disease—Population biology and evolution , 2009, Vaccine.

[80]  M. Suchard,et al.  Smooth skyride through a rough skyline: Bayesian coalescent-based inference of population dynamics. , 2008, Molecular biology and evolution.

[81]  S. Gandon,et al.  Applying population-genetic models in theoretical evolutionary epidemiology. , 2007, Ecology letters.

[82]  J. Mertsola,et al.  Population dynamics of Bordetella pertussis in Finland and Sweden, neighbouring countries with different vaccination histories. , 2007, Vaccine.

[83]  T. Tam,et al.  The Effect of Changing From Whole-Cell to Acellular Pertussis Vaccine on the Epidemiology of Hospitalized Children With Pertussis in Canada , 2007, The Pediatric infectious disease journal.

[84]  E. Anis,et al.  The re-emergence of pertussis in Israel. , 2006, The Israel Medical Association journal : IMAJ.

[85]  S. Ho,et al.  Relaxed Phylogenetics and Dating with Confidence , 2006, PLoS biology.

[86]  J. Kaldor,et al.  National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases. , 2004, Communicable diseases intelligence quarterly report.

[87]  B. Barrell,et al.  Comparative analysis of the genome sequences of Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica , 2003, Nature Genetics.

[88]  M Travisano,et al.  Long-term experimental evolution in Escherichia coli. IV. Targets of selection and the specificity of adaptation. , 1996, Genetics.

[89]  E. Myers,et al.  Basic local alignment search tool. , 1990, Journal of molecular biology.

[90]  P. Fine,et al.  Reflections on the efficacy of pertussis vaccines. , 1987, Reviews of infectious diseases.

[91]  A. Saah,et al.  Acellular and whole-cell pertussis vaccines in Japan. Report of a visit by US scientists. , 1987, JAMA.

[92]  S. Tavaré Some probabilistic and statistical problems in the analysis of DNA sequences , 1986 .